Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tatiana G, Ryabicheva"'
Autor:
Evgeniya V. Dolgova, Svetlana S. Kirikovich, Evgeniy V. Levites, Vera S. Ruzanova, Anastasia S. Proskurina, Genrikh S. Ritter, Oleg S. Taranov, Nikolay A. Varaksin, Tatiana G. Ryabicheva, Olga Yu. Leplina, Alexandr A. Ostanin, Elena R. Chernykh, Sergey S. Bogachev
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 15, p 8075 (2022)
The main problem related to the studies focusing on group-specific component protein-derived macrophage-activating factor (GcMAF) is the lack of clarity about changes occurring in different types of macrophages and related changes in their properties
Externí odkaz:
https://doaj.org/article/58b5aa06708746aeac6e144ec5a55a13
Autor:
Nikolay A. Varaksin, Vera S. Ruzanova, S. S. Kirikovich, Tatiana G. Ryabicheva, A. S. Proskurina, E. Ya. Shevela, Yu. G. Druzhinina, S. S. Bogachev, Alexandr A. Ostanin, E. V. Dolgova, Evgeniy V. Levites, O. Yu. Leplina, Genrikh S. Ritter, Elena R. Chernykh, S. L. Ryzhikova
Publikováno v:
Medicinskaâ Immunologiâ, Vol 23, Iss 2, Pp 257-274 (2021)
This article is the second communication in a series of articles devoted to the effects of a domestic preparation of macrophage-activating factor (GcMAF-RF) and assessment of its biological properties. The aim of this work was to study the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee4aa1614662fecf6b8a5ade5bebe07
https://doi.org/10.15789/1563-0625-eom-2132
https://doi.org/10.15789/1563-0625-eom-2132
Autor:
Tatiana G. Ryabicheva, A. V. Romashchenko, Elena R. Chernykh, Aleksandr M Goryachkin, Natalia V Yurina, Alexandr A. Ostanin, Sergey S. Bogachev, Nikolay A. Varaksin, Anastasia S. Proskurina, Alexey V Purtov, Tatiana A Ageeva
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Natalia V Yurina,1 Tatiana A Ageeva,2 Aleksandr M Goryachkin,2 Nikolay A Varaksin,3 Tatiana G Ryabicheva,3 Alexandr A Ostanin,4 Elena R Chernykh,4 Alexander V Romashchenko,5 Anastasia S Proskurina,5 Sergey Bogachev,5 Alexey V Purtov6 1Autonomous Non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e447a70f96c5df2ab6eea4f45829915d
https://pubmed.ncbi.nlm.nih.gov/33679135
https://pubmed.ncbi.nlm.nih.gov/33679135
Autor:
Anastasia S, Proskurina, Alisa V, Spaselnikova, Genrikh S, Ritter, Evgenia V, Dolgova, Ekaterina A, Potter, Margarita V, Romanenko, Sergey V, Netesov, Yaroslav R, Efremov, Oleg S, Taranov, Nikolay A, Varaksin, Tatiana G, Ryabicheva, Aleksandr A, Ostanin, Elena R, Chernykh, Sergey S, Bogachev
Publikováno v:
European cytokine network. 30(2)
The present study demonstrates that monocyte-derived dendritic cells (moDCs) produced in vitro using a GM-CSF and IFN-α differentiation protocol encompass a rare (∼5%) subpopulation of cells showing classical dendritic cell morphology and capable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6eaf46fccdb78050fa14c6a13a0291d6
https://pubmed.ncbi.nlm.nih.gov/31486403
https://pubmed.ncbi.nlm.nih.gov/31486403
Autor:
Tatiana G. Ryabicheva, Ekaterina A. Potter, Vladimir A. Rogachev, S V Sidorov, Olga Leplina, Tatiana S. Gvozdeva, Alexandr A. Ostanin, Victoria V. Dvornichenko, Nelly A. Popova, Dmitriy M Ponomarenko, Elena R. Chernykh, Galina S. Soldatova, Valeriy P. Nikolin, Konstantin E. Orishchenko, Anastasia S. Proskurina, Peter N. Uchakin, Nikolay A. Varaksin, Mikhail A. Shurdov, Sergey S. Bogachev, Evgenia V. Dolgova
Publikováno v:
BMC Cancer
Background We report on the results of a phase II clinical trial of Panagen (tablet form of fragmented human DNA preparation) in breast cancer patients (placebo group n = 23, Panagen n = 57). Panagen was administered as an adjuvant leukoprotective ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c9e2507a0ec147dea6f0468d7dd37a
https://doi.org/10.1186/s12885-016-2711-5
https://doi.org/10.1186/s12885-016-2711-5
Autor:
Anastasia S. Proskurina, Tatiana S. Gvozdeva, Ekaterina A. Alyamkina, Evgenia V. Dolgova, Konstantin E. Orishchenko, Valeriy P. Nikolin, Nelly A. Popova, Sergey V. Sidorov, Elena R. Chernykh, Alexandr A. Ostanin, Olga Y. Leplina, Victoria V. Dvornichenko, Dmitriy M. Ponomarenko, Galina S. Soldatova, Nikolay A. Varaksin, Tatiana G. Ryabicheva, Peter N. Uchakin, Stanislav N. Zagrebelniy, Vladimir A. Rogachev, Sergey S. Bogachev, Mikhail A. Shurdov
Publikováno v:
BMC Cancer. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41501d72c725792dba770cbb0053e9d5
https://doi.org/10.1186/s12885-016-2163-y
https://doi.org/10.1186/s12885-016-2163-y
Autor:
Victoria V. Dvornichenko, Valeriy P. Nikolin, Tatiana G. Ryabicheva, Peter N. Uchakin, Tatiana S. Gvozdeva, Vladimir A. Rogachev, S V Sidorov, Nelly A. Popova, Konstantin E. Orishchenko, Mikhail A. Shurdov, Dmitriy M Ponomarenko, Sergey S. Bogachev, Elena R. Chernykh, Evgenia V. Dolgova, Stanislav N. Zagrebelniy, Galina S. Soldatova, Ekaterina A. Alyamkina, Olga Leplina, Nikolay A. Varaksin, Alexandr A. Ostanin, Anastasia S. Proskurina
Publikováno v:
BMC Cancer
Background We performed a multicenter, double-blind, placebo-controlled, phase II clinical trial of human dsDNA-based preparation Panagen in a tablet form. In total, 80 female patients with stage II-IV breast cancer were recruited. Methods Patients r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c1bb6b0b17cd52789a1410f29cdff9
https://pubmed.ncbi.nlm.nih.gov/26887451
https://pubmed.ncbi.nlm.nih.gov/26887451